NLRP3 and cancer: Indeed, our analysis of NLRP3 (and CASP1 and IL‐1β) expression in 90 pediatric ALL PDX samples (PPTC data set)19 using the PedcBioPortal database confirmed higher NLRP3 mRNA expression in ALL compared to other cancer types.